Icandra (previously Vildagliptin / metformin hydrochloride Novartis) Euroopan unioni - espanja - EMA (European Medicines Agency)

icandra (previously vildagliptin / metformin hydrochloride novartis)

novartis europharm limited - vildagliptina, metformin hidrocloruro - diabetes mellitus, tipo 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 y 5. 1 para datos disponibles sobre diferentes combinaciones).

Zomarist Euroopan unioni - espanja - EMA (European Medicines Agency)

zomarist

novartis europharm limited  - vildagliptina, metformin hidrocloruro - diabetes mellitus, tipo 2 - drogas usadas en diabetes - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.

GALVUS MET 50/500 mg comprimido recubierto Uruguay - espanja - Ministerio de Salud (Dirección Oficina Central)

galvus met 50/500 mg comprimido recubierto

scienza uruguay - comprimido recubierto - vildagliptina 50 mg + metformina 500 mg comprimido

GALVUS MET 50/850 mg comprimido recubierto Uruguay - espanja - Ministerio de Salud (Dirección Oficina Central)

galvus met 50/850 mg comprimido recubierto

scienza uruguay - comprimido recubierto - vildagliptina 50 mg + metformina 850 mg comprimido

GIAMEBIL 160mg COMPRIMIDO Peru - espanja - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

giamebil 160mg comprimido

hebron del peru s.a.c. industria quimica y farmaceutica - comprimido - por comprimido; mentha crispa 8.000000 ml; - metformina y vildagliptina

VGLIPTMET 50mg + 850 mg TABLETA RECUBIERTA Peru - espanja - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

vgliptmet 50mg + 850 mg tableta recubierta

qualis pharma s.a.c. - droguerÍa - tableta recubierta - por tableta - - metformina y vildagliptina

VGLIPTMET 50mg + 1000mg TABLETA RECUBIERTA Peru - espanja - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

vgliptmet 50mg + 1000mg tableta recubierta

qualis pharma s.a.c. - droguerÍa - tableta recubierta - por tableta - - metformina y vildagliptina

ODASEN 50 50 mg COMPRIMIDO RECUBIERTO Peru - espanja - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

odasen 50 50 mg comprimido recubierto

mega labs latam s.a. - droguerÍa - comprimido recubierto - por comprimido - - metformina y vildagliptina

INTELECTUM CAPSULA Peru - espanja - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

intelectum capsula

eurofarma peru s.a.c. - capsula - por comprimido; lechaza de pescado 12.000000 mg; vitamina e (tocoferol) 19.990000 mg; aceite de pescado 135.000000 mg; beta caroteno 6.670000 mg; lecitina de soja 193.330000 mg; esteres de acidos grasos 40.950000 mg; - metformina y vildagliptina

Vildagliptin / Metformin hydrochloride Accord Euroopan unioni - espanja - EMA (European Medicines Agency)

vildagliptin / metformin hydrochloride accord

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabetes mellitus, tipo 2 - drogas usadas en diabetes - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 y 5. 1 para datos disponibles sobre diferentes combinaciones).